Skip to main content

Medly Pharmacy raises $100 million in a Series B funding round

The Brooklyn-based company said the funding round was co-led by Boston growth equity firm Volition Capital and venture capital firm Greycroft with participation from Horsley Bridge and Lerer Hippeau.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.